(Adds comments, updates prices)
* Vaccine euphoria likely to grip gold in near-term -analyst
* Interactive graphic tracking global spread of coronavirus:
https://tmsnrt.rs/3mvcUoa
By Nakul Iyer
Dec 14 (Reuters) - Gold prices dipped on Monday as COVID-19
vaccine rollouts lifted riskier assets, overshadowing hopes for
further U.S. fiscal and monetary stimulus.
Spot gold XAU= fell 0.4% to $1,831.75 per ounce by 0746
GMT, while U.S. gold futures GCv1 eased 0.4% to $1,836.80.
"The euphoria around a COVID-19 vaccine will likely
overshadow further easing from the Federal Reserve and a fiscal
relief package in the near term," said Howie Lee, an economist
at OCBC Bank.
"But gold could rally in 2021 when the vaccine optimism dies
down and investors' focus returns to rising inflation
expectations due to the large swathe of monetary and fiscal
stimulus the U.S. economy still requires."
The first shipments of Pfizer Inc PFE.N and BioNTech SE's
BNTX.O coronavirus vaccine in the United States began on
Sunday, lifting Asian equities. MKTS/GLOB But, limiting gold's losses were reports that a $908 billion
U.S. COVID-19 relief plan could be introduced as early as Monday
as a leading Democrat lawmaker suggested his party might be
willing to reach a compromise.
Investors now await the U.S Federal Reserve's two-day policy
meeting starting on Tuesday with bets for increased purchases of
longer-dated Treasuries to contain a rise in yields, which also
weighed on the dollar. USD/
"Gold could rise even if a fiscal stimulus deal isn't
reached as long as the Fed manages to compress yields with the
collapse in negotiations ahead of the meeting, potentially
necessitating more aggressive monetary action," OANDA analyst
Craig Erlam said.
Gold, considered a hedge against inflation and currency
debasement, tends to benefit from lower interest rates that
reduces its opportunity cost.
Silver XAG= fell 0.1% to $23.88 an ounce, while platinum
XPT= rose 0.9% to $1,018.21 and palladium XPD= gained 0.3%
to $2,324.48.